Increase of Cyclooxygenase-2 Expression by Interleukin 15 in Rheumatoid Synoviocytes

Journal of Rheumatology

Volumn 31, Issue 5, 2004, Pages 875-883

  Min, So Youn ^a   Hwang, Sue Yun ^a   Jung, Young Ok ^b   Jeong, Jinyoung ^c   Park, Sung Hwan ^d   Cho, Chul Soo ^d   Kim, Ho Youn ^d   Kim, Wan Uk ^c  

^a The Catholic University of Korea   (South Korea)

^b Hallym University   (South Korea)

^c The Catholic University of Korea   (South Korea)

^d The Catholic University of Korea   (South Korea)

Author keywords

Cyclooxygenase 2; Interleukin 15; Nuclear factor B; Synoviocytes

Indexed keywords

CURCUMIN; CYCLOOXYGENASE 2; DEXAMETHASONE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 15; INTERLEUKIN 1BETA; PROSTAGLANDIN E2; PYRROLIDINE DITHIOCARBAMATE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE; SYNOVIUM; WESTERN BLOTTING;

ANTIBODIES, BLOCKING; ARTHRITIS, RHEUMATOID; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLOOXYGENASE 2; DEXAMETHASONE; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-15; ISOENZYMES; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NF-KAPPA B; PROLINE; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; RNA, MESSENGER; SYNOVIAL MEMBRANE; THIOCARBAMATES; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 2342468049     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Gay S, Gay RE, Koopman WJ. Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52:39-47.
2. Hamilton JA. Hypothesis: in vitro evidence for the invasive and tumor-like properties of the rheumatoid pannus. J Rheumatol 1983;10:845-51.
3. Firestein GS. Invasive fibroblast-like synoviocytes in rheumatoid arthritis. Passive responders or transformed aggressors? Arthritis Rheum 1996;39:1781-90.
4. Fehniger TA, Caligiuri MA. Interleukin 15: biology and relevance to human disease. Blood 2001;97:14-32.
5. Harada S, Yamamura M, Okamoto H, et al. Production of interleukin-7 and interleukin-15 by fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1508-16.
6. McInnes IB, Leung BP, Sturrock RD, Field M, Liew FY. Interleukin-15 mediates T cell-dependent regulation of tumor necrosis factor-α production in rheumatoid arthritis. Nature Med 1997;3:189-95.
7. McInnes IB, al-Mughales J, Field M, et al. The role of interleukin-15 in T-cell migration and activation in rheumatoid arthritis. Nature Med 1996;2:175-82.
8. Kurowska M, Rudnicka W, Kontny E, et al. Fibroblast-like synoviocytes from rheumatoid arthritis patients express functional IL-15 receptor complex: endogenous IL-15 in autocrine fashion enhances cell proliferation and expression of Bcl-x(L) and Bcl-2. J Immunol 2002; 169:1760-7.
9. Cao C, Matsumura K, Yamagata K, Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 1997;272:R1712-25.
10. Crofford LJ, Wilder RL, Ristimaki AP, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1β, phorbol ester, and corticosteroids. J Clin Invest 1994;93:1095-101.
11. Siegle I, Klein T, Backman JT, Saal JG, Nusing RM, Fritz P. Expression of cyclooxygenase 1 and cyclooxygenase 2 in human synovial tissue: differential elevation of cyclooxygenase 2 in inflammatory joint diseases. Arthritis Rheum 1998;41:122-9.
12. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996;97:2672-9.
13. Myers LK, Kang AH, Postlethwaite AE, et al. The genetic ablation of cyclooxygenase 2 prevents the development of autoimmune arthritis. Arthritis Rheum 2000;43:2687-93.
14. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthase (cyclooxygenases)-1 and -2. J Biol Chem 1996;271:33157-60.
15. Endo T, Ogushi F, Sone S. LPS-dependent cyclooxygenase-2 induction in human monocytes is down-regulated by IL-13, but not by IFN-γ. J Immunol 1996;156:2240-6.
16. DuBois RN, Tsujii M, Bishop P, Awad JA, Makita K, Lanahan A. Cloning and characterization of a growth factor-inducible cyclooxygenase gene from rat intestinal epithelial cells. Am J Physiol 1994;266:G822-7.
17. Minghetti L, Walsh DT, Levi G, Perry VH. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines. J Neuropathol Exp Neurol 1999;58:1184-91.
18. Vlahos R, Stewart AG. Interleukin-1α and tumour necrosis factor-α modulate airway smooth muscle DNA synthesis by induction of cyclo-oxygenase-2: inhibition by dexamethasone and fluticasone propionate. Br J Pharmacol 1999;126:1315-24.
19. Barrios-Rodiles M, Chadee K. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-γ in human macrophages. J Immunol 1998;161:2441-8.
20. Niiro H, Otsuka T, Izuhara K, et al. Regulation by interleukin-10 and interleukin-4 of cyclooxygenase-2 expression in human neutrophils. Blood 1997;89:1621-8.
21. Niiro H, Otsuka T, Tanabe T, et al. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 1995;85:3736-45.
22. Appleby SB, Ristimaki A, Neilson K, Narko K, Hla T. Structure of the human cyclo-oxygenase-2 gene. Biochem J 1994;302:723-7.
23. Cho ML, Kim WU, Min SY, et al. Cyclosporine differentially regulates interleukin-10, interleukin-15, and tumor necrosis factor-α production by rheumatoid synoviocytes. Arthritis Rheum 2002;46:42-51.
24. Jeong JY, Jue DM. Chloroquine inhibits processing of tumor necrosis factor in lipopolysaccharide-stimulated RAW 264.7 macrophages. J Immunol 1997;158:4901-7.
25. McDonald PP, Russo MP, Ferrini S, Cassatella MA. Interleukin-15 (IL-15) induces NF-κB activation and IL-8 production in human neutrophils. Blood 1998;92:4828-35.
26. Brostjan C, Anrather J, Csizmadia V, Natarajan G, Winkler H. Glucocorticoids inhibit E-selectin expression by targeting NF-κB and not ATF/c-Jun. J Immunol 1997;158:3836-44.
27. Ziegler-Heitbrock HW, Sternsdorf T, Liese J, et al. Pyrrolidine dithiocarbamate inhibits NF-κB mobilization and TNF production in human monocytes. J Immunol 1993;151:6986-93.
28. Crofford LJ, Tan B, McCarthy CJ, Hla T. Involvement of nuclear factor κB in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997;40:226-36.
29. Baird NR, Morrison AR. Amplification of the arachidonic acid cascade: implications for pharmacologic intervention. Am J Kidney Dis 1993;1:557-64.
30. Bidgood MJ, Jamal OS, Cunningham AM, Brooks PM, Scott KF. Type II A secretory phospholipase A2 upregulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes. J Immunol 2000;165:2790-7.
31. Ziolkowska M, Koc A, Luszczykiewicz G, et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000;164:2832-8.
32. Miossec P, van den Berg W. Th1/Th2 cytokine balance in arthritis. Arthritis Rheum 1997;40:2105-15.
33. Fujisawa K, Aono H, Hasunuma T, Yamamoto K, Mita S, Nishioka K. Activation of transcription factor NF-κB in human synovial cells in response to tumor necrosis factor α. Arthritis Rheum 1996;39:197-203.
34. Rodel J, Straube E, Lungershausen W, Hartmann M, Groh A. Secretion of cytokines by human synoviocytes during in vitro infection with Chlamydia trachomatis. J Rheumatol 1998;25:2161-8.
35. Giri JG, Kumaki S, Ahdieh M, et al. Identification and cloning of a novel IL-15 binding protein that is structurally related to the α-chain of the IL-2 receptor. EMBO J 1995;14:3654-63.
36. Bulanova E, Budagian V, Pohl T, et al. The IL-15Rα chain signals through association with Syk in human B cells. J Immunol 2001;167:6292-302.
37. Glinghammar B, Inoue H, Rafter JJ. Deoxycholic acid causes DNA damage in colonic cells with subsequent induction of caspases, COX-2 promoter activity and the transcription factors NF-κB and AP-1. Carcinogenesis 2002;23:839-45.
38. Ristimaki A, Garfinkel S, Wessendorf J, Maciag T, Hla T. Induction of cyclooxygenase-2 by interleukin-1α. Evidence for post-transcriptional regulation. J Biol Chem 1994;269:11769-75.
39. 2 regulates the level and stability of cyclooxygenase-2 mRNA through activation of p38 mitogen-activated protein kinase in interleukin-1β-treated human synovial fibroblasts. J Biol Chem 2001;276:31720-31.
40. Ristimaki A, Narko K, Hla T. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: evidence for post-transcriptional regulation. Biochem J 1996;318:325-31.
41. 2 on interleukin-1β-induced cyclooxygenase-2 expression in human airway smooth-muscle cells. Am J Respir Crit Care Med 2000;162:2272-7.
42. 2, cyclic AMP and non-steroidal anti-inflammatory drugs. Eur J Neurosci 1997;9:934-40.